OCTOSTIM sol inj 15 mcg/ml 10 fl 1 ml
7680527110296
CH-52711
H01BA02
06.02.0.
Reimbursement limitations:
OCTOSTIM
Hémophilie A et maladie de von Willebrand Type I.
1 / 3
google
Details
- Product number
- 5271101
- CPT
- -
- Packaging group
- 10 x 1 mL
- Unit
- Ampulle(n)
- Composition
- desmopressini acetas 15 µg corresp. desmopressinum 13.4 µg, natrii chloridum corresp. natrium 3.54 mg, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml.
Articles (1)
Octostim 15 ug, Injektions-/Infusionslösung
Ampullen
10 x 1 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 UG | Substance | WIZUS |
|
(N/A)
|
13.4 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 296.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1995
Authorization holder
Ferring AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 52711
- Drug name
- Octostim, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- H01BA02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/06/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 06.02.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OCTOSTIM sol inj 15 mcg/ml 10 fl 1 ml
- Description (DE)
- OCTOSTIM Inj Lös 15 mcg/ml 10 Fl 1 ml
- Market launch
- 20/06/1994
- Narcotic (BTM)
- No